This is a non-core endpoint: only basic statistics are computed.

See these related core endpoints for full statistics:

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

DOID EFO MESH SNOMED

H7_USEOFEYEANTIALLERGENS

conjunctivitis: Inflammation of the conjunctiva of the eye. [ NCIT:P378 ]

Endpoint definition

↥

FinnGen phenotype data

392423 individuals

diagram downward connector

Apply sex-specific rule None

392423

diagram downward connector

Check conditions None

392423

diagram downward connector

Check pre-conditions, main-only, mode, registry filters

Medicine purchases: ATC S01GX

1 out of 7 registries used, show all original rules.

20865

diagram downward connector

Check minimum number of events

Min. number of events 3

20865

diagram downward connector

Include endpoints None

20865

diagram downward connector

diagram downward connector

Remove individuals based on genotype QC

20147

diagram downward connector

H7_USEOFEYEANTIALLERGENS

Control definitions

Control exclude H7_CONJUNCTIVA

Extra metadata

Level in the ICD hierarchy 4

First used in FinnGen datafreeze DF2

NAME	H7_USEOFEYEANTIALLERGENS
CONTROL_EXCLUDE	H7_CONJUNCTIVA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC	S01GX
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Show upset plot detailing case counts by codes

Or the full data table

Similar endpoints

↥

List of similar endpoints to Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis) based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	20147	15517	4630
Unadjusted prevalence (%)	5.34	7.36	2.78
Mean age at first event (years)	37.12	37.72	35.11

Mortality

Not a core endpoint, no data to show.

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Not a core endpoint, no data to show.

Correlations

↥

Index endpoint: H7_USEOFEYEANTIALLERGENS – Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)
GWS hits:

Survival analyses between endpoints

↥

Not a core endpoint, no data to show.

Drugs most likely to be purchased after Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

↥

Endpoint not on priority list, no data to show.